Selz Capital LLC Takes Position in CME Group Inc (NASDAQ:CME)

Share on StockTwits

Selz Capital LLC bought a new position in shares of CME Group Inc (NASDAQ:CME) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 53,000 shares of the financial services provider’s stock, valued at approximately $10,638,000. CME Group comprises approximately 1.9% of Selz Capital LLC’s portfolio, making the stock its 17th biggest position.

Several other hedge funds have also recently added to or reduced their stakes in the company. Nuveen Asset Management LLC grew its holdings in CME Group by 18,355.3% during the 2nd quarter. Nuveen Asset Management LLC now owns 3,238,530 shares of the financial services provider’s stock worth $628,631,000 after acquiring an additional 3,220,982 shares during the period. Amundi Pioneer Asset Management Inc. boosted its holdings in CME Group by 30.4% during the second quarter. Amundi Pioneer Asset Management Inc. now owns 1,664,500 shares of the financial services provider’s stock worth $323,097,000 after buying an additional 388,008 shares during the last quarter. Vanguard Group Inc. boosted its holdings in CME Group by 1.2% during the second quarter. Vanguard Group Inc. now owns 27,992,457 shares of the financial services provider’s stock worth $5,433,616,000 after buying an additional 328,318 shares during the last quarter. Invesco Ltd. grew its position in shares of CME Group by 20.0% during the 2nd quarter. Invesco Ltd. now owns 1,310,510 shares of the financial services provider’s stock worth $254,384,000 after buying an additional 218,421 shares during the period. Finally, California Public Employees Retirement System grew its position in shares of CME Group by 11.5% during the 3rd quarter. California Public Employees Retirement System now owns 1,940,906 shares of the financial services provider’s stock worth $410,191,000 after buying an additional 200,245 shares during the period. Institutional investors own 84.14% of the company’s stock.

CME has been the subject of a number of recent analyst reports. BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research note on Friday, January 10th. ValuEngine cut shares of CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. JPMorgan Chase & Co. lowered their target price on shares of CME Group from $183.00 to $173.00 and set an “underweight” rating for the company in a research note on Friday, December 6th. Citigroup upped their target price on shares of CME Group from $220.00 to $240.00 and gave the company a “buy” rating in a research note on Monday, October 21st. Finally, UBS Group increased their target price on shares of CME Group from $218.00 to $221.00 and gave the stock a “neutral” rating in a report on Wednesday, December 4th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and five have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $208.36.

In other news, Director Martin J. Gepsman sold 1,000 shares of the stock in a transaction on Friday, January 3rd. The shares were sold at an average price of $201.16, for a total transaction of $201,160.00. Following the completion of the sale, the director now owns 34,905 shares of the company’s stock, valued at $7,021,489.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Terrence A. Duffy sold 39,309 shares of the stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $202.38, for a total transaction of $7,955,355.42. Following the sale, the chief executive officer now directly owns 46,684 shares of the company’s stock, valued at approximately $9,447,907.92. The disclosure for this sale can be found here. Over the last quarter, insiders sold 40,609 shares of company stock worth $8,216,221. Company insiders own 1.20% of the company’s stock.

CME traded up $0.42 during mid-day trading on Thursday, hitting $206.41. The stock had a trading volume of 22,108 shares, compared to its average volume of 1,221,835. The stock’s fifty day simple moving average is $203.77 and its 200-day simple moving average is $206.89. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.04 and a quick ratio of 1.04. The firm has a market capitalization of $72.95 billion, a price-to-earnings ratio of 30.24, a price-to-earnings-growth ratio of 3.46 and a beta of 0.18. CME Group Inc has a 1-year low of $161.05 and a 1-year high of $224.91.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 30th. The financial services provider reported $1.90 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.75 by $0.15. The company had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.27 billion. CME Group had a net margin of 40.93% and a return on equity of 9.54%. The business’s revenue for the quarter was up 41.3% compared to the same quarter last year. During the same period last year, the business posted $1.45 earnings per share. As a group, research analysts expect that CME Group Inc will post 6.81 earnings per share for the current fiscal year.

The company also recently announced a dividend, which was paid on Wednesday, January 15th. Shareholders of record on Friday, December 27th were issued a $2.50 dividend. The ex-dividend date of this dividend was Thursday, December 26th. This is a positive change from CME Group’s previous dividend of $1.75. CME Group’s dividend payout ratio (DPR) is 43.99%.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Recommended Story: Market Perform

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.